- Home
- INTR vs HRMY Comparison
INTR vs HRMY Comparison
Compare INTR & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTR
- HRMY
- Stock Information
- Founded
- INTR 1994
- HRMY 2017
- Country
- INTR Brazil
- HRMY United States
- Employees
- INTR N/A
- HRMY N/A
- Industry
- INTR
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- INTR
- HRMY Health Care
- Exchange
- INTR Nasdaq
- HRMY Nasdaq
- Market Cap
- INTR 2.1B
- HRMY 2.0B
- IPO Year
- INTR N/A
- HRMY 2020
- Fundamental
- Price
- INTR $4.75
- HRMY $40.46
- Analyst Decision
- INTR Strong Buy
- HRMY Strong Buy
- Analyst Count
- INTR 4
- HRMY 8
- Target Price
- INTR $7.13
- HRMY $55.00
- AVG Volume (30 Days)
- INTR 1.8M
- HRMY 596.7K
- Earning Date
- INTR 02-06-2025
- HRMY 02-20-2025
- Dividend Yield
- INTR 2.54%
- HRMY N/A
- EPS Growth
- INTR 295.93
- HRMY N/A
- EPS
- INTR 0.33
- HRMY 2.11
- Revenue
- INTR $767,729,562.00
- HRMY $681,879,000.00
- Revenue This Year
- INTR N/A
- HRMY $24.79
- Revenue Next Year
- INTR $24.01
- HRMY $19.00
- P/E Ratio
- INTR $14.17
- HRMY $19.29
- Revenue Growth
- INTR 38.44
- HRMY 25.83
- 52 Week Low
- INTR $3.88
- HRMY $28.14
- 52 Week High
- INTR $7.84
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- INTR 57.46
- HRMY 75.22
- Support Level
- INTR $4.20
- HRMY $35.72
- Resistance Level
- INTR $4.84
- HRMY $37.16
- Average True Range (ATR)
- INTR 0.13
- HRMY 1.29
- MACD
- INTR 0.11
- HRMY 0.60
- Stochastic Oscillator
- INTR 89.29
- HRMY 93.95
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop & Commerce Plus. It generates maximum revenue from the Banking & Spending.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.